VTVT vtvtherapeutics.com Earnings growth forecast for next year

Corporate emblem and logo of vTv Therapeutics Inc (VTVT)

The competent management of vTv Therapeutics Inc. (VTVT) has stabilized the biotech's operations by raising capital for Type 1 diabetes research and mitigating risks through strategic partners. The trend for expected net income per share on the GURU.Markets chart clearly demonstrates a trajectory where -123.80 becomes the new value for this metric. However, the absence of commercial products and negative cash flow leave the business dependent on grants.

vTv Therapeutics Inc (VTVT): Expected net earnings per share growth next year from 07/04/2022 to 11/18/2026

VTVT (vTv Therapeutics Inc): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:VTVT, vTv Therapeutics, Inc.
Finished products of vTv Therapeutics, Inc.

vTv Therapeutics Inc. (VTVT) is betting on unique software for diabetes therapy, which minimizes pricing risks within the biotech sector. By analyzing the valuation of forward net income growth rates, an investor can see the consensus forecast for future earnings per share relative to current performance. An excessive gap between these expectations and the actual execution of the business plan often signals an overvaluation of the asset ahead of an inevitable correction in market prices.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|MBX (MBX Biosciences Inc) - Projected earnings per share growth rate for next year|ALT: Earnings growth forecast for next year|Aardvark Therapeutics Inc - Expected earnings per share trend next year|SGMT (Sagimet Biosciences, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year BioAge|Earnings growth forecast for next year BMEA|Expected earnings per share growth for next year Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year ATPC|Pluristem Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year synlogictx.com SYBX|LPCN: Earnings growth forecast for next year|Matinas BioPharma Holdings, Inc. - Expected earnings per share trend next year|SPRB (Spruce Biosciences Inc.) - Earnings growth forecast for next year|galecto.com (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year organovo.com ONVO|Radius Health (RDUS) - Expected net earnings per share growth next year